AIMED TRIAL SRL

FASTER, BETTER AND CHEAPER CLINICAL TRIALS WITH REAL WORLD DATA (RWD)

AIMED TRIAL WAS FOUNDED IN 2022 AS PART OF PROJECT SUPPORTED BY THE EUROPEAN INSTITUTE OF INNOVATION AND TECHNOLOGY (EIT DIGITAL)

We support Sponsors of Clinical Trials to make the trial feasible in shorter period of time, at lower costs and with regulatory acceptance.

• AIMED leverages advanced Artificial Intelligence techniques to transform RWD into actionable insights which can help to accelerate drug development through faster and cheaper clinical trials
• Thanks to our expertise and extensive access to RWD, we are able to support our clients in accelerated drug development, regulatory submissions and successful access into new markets